Drug Investigation

, Volume 5, Supplement 1, pp 68–72

Human Pharmacokinetics of Aniracetam

  • G. Roncari
Article

DOI: 10.1007/BF03258428

Cite this article as:
Roncari, G. Drug Invest (1993) 5(Suppl 1): 68. doi:10.1007/BF03258428

Summary

Aniracetam is very rapidly and completely absorbed from the gastrointestinal tract. However, absolute systemic bioavailability is only about 0.2%. Aniracetam has a high volume of distribution (2.5 L/kg, which implies extensive extravascular distribution) and is very rapidly eliminated from the body. Indeed, total body clearance from blood (10 L/min) exceeds cardiac output (implying that the lung is a major clearance organ) and plasma elimination half-life is very short (≈ 0.5 hours). Aniracetam is completely metabolised and the principal metabolites, N-anisoyl-γ-aminobutyric acid (N-anisoyl-GABA), 2-pyrrolidinone, succinimide and anisic acid, are excreted via the urine (84%), the faeces (2%) or as CO2 in expired air. After multiple dose administration, there is no indication of accumulation of drug or principal metabolites, with the exception of succinimide. Measurable concentrations of 2 main metabolites, N-anisoyl-GABA and 2-pyrrolidinone, were found in the cerebrospinal fluid of patients treated with aniracetam for 12 weeks.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Adis International Limited 1993

Authors and Affiliations

  • G. Roncari
    • 1
  1. 1.Pharma Division, Department of Clinical ResearchF. Hoffmann-La Roche LtdBaselSwitzerland

Personalised recommendations